Latest Investor Relations News

Alligator Energy reports a 10% increase in indicated uranium resources at its Samphire Project, secures a $17.25 million capital raise, and announces a CEO transition as it advances key uranium exploration and development milestones.

Kingsland Minerals has withdrawn its previously implied production target for the Leliyn Graphite Project’s processing plant, citing non-compliance with ASX disclosure rules and advising investors to disregard prior estimates.

Prescient Therapeutics has extended the closing date of its Share Purchase Plan to July 25, 2025, responding to shareholder demand and reinforcing strong participation. The oncology-focused biotech also highlights upcoming clinical milestones and ongoing investor engagement.

Austal Limited has acknowledged a delayed filing of a director's interest notice due to an administrative oversight, prompting ASX scrutiny and a commitment to tighten compliance processes.

Beacon Minerals has announced a $12 million on-market share buy-back program aiming to enhance shareholder value and capital efficiency, with purchases starting August 1, 2025.

Broken Hill Mines Limited will have its trading suspension lifted on 21 July 2025, marking its return to the ASX following successful compliance with listing rules.

Hydrocarbon Dynamics Limited has announced a 1 for 3 entitlement offer to raise up to $718,000, aiming to fund marketing of its HCD Multi-Flow® product and explore new energy technology investments.

Adherium Limited has successfully completed a $4.49 million entitlement offer, combining institutional and retail components, to fund expansion of its Hailie® digital respiratory monitoring platform.

Bowen Coking Coal Ltd has been hit with a $6.8 million statutory demand from contractor BUMA Australia, raising the spectre of insolvency if unresolved within 21 days. The dispute centers on claims and counterclaims involving liquidated damages.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

The ASX has published its latest list of entities suspended from trading for over three months, outlining key deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines risks removal from the official list.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.